Clinical Trial Update: Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a molecular analysis–based strategy to empiric treatment in patients with cancer of unknown primary; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms Unknown Primary

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Neoplasms, Unknown Primary | Phase 3 | Status: COMPLETED